ICON Public Limited Company (ICLR) Financials

ICLR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 16.4 billion 7.0 billion
March 31, 2026 16.3 billion 7.0 billion
Dec. 31, 2025 16.3 billion 7.1 billion
Sept. 30, 2025 16.5 billion 7.2 billion

ICLR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 235.3 million 18.5 million
March 31, 2026 136.2 million 27.6 million
Dec. 31, 2025 622.7 million 89.7 million
Sept. 30, 2025 351.9 million 60.2 million

ICLR Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 72.6 million
March 31, 2026 104.8 million
Dec. 31, 2025 68.5 million
Sept. 30, 2025 2.4 million

ICLR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 928.4 million 2.1 billion 102.8 million
March 31, 2026 765.2 million 2.9 billion 111.3 million
Dec. 31, 2025 647.3 million 2.9 billion 153.4 million
Sept. 30, 2025 468.9 million 2.9 billion 125.1 million

ICLR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 77.4 million
March 31, 2026 77.3 million
Dec. 31, 2025 76.6 million
Sept. 30, 2025 78.1 million

ICLR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 42.2 million - 194.3 million -
March 31, 2026 30.8 million - 200.6 million -
Dec. 31, 2025 145.3 million - 179.7 million -
Sept. 30, 2025 56.6 million - 197.0 million -

ICLR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.1 billion 1.7 billion
March 31, 2026 2.0 billion 1.6 billion
Dec. 31, 2025 2.1 billion 1.6 billion
Sept. 30, 2025 2.0 billion 1.6 billion

ICLR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ICLR

Price: $164.85

52 week price:
66.57
203.91

Earnings Per Share: 0.65 USD

P/E Ratio: 241.31

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: Ireland

Volume: 457160

Ebitda: 105.9 million

Market Capitalization: 12.3 billion

Links: